Jagriti Bhatia
(Corresponding
author)
|
Department of Pharmacology, All India Institute of Medical
Sciences, New Delhi - 110 029, India
e-mail: jagriti2012@gmail.com
|
Publication Data
Paper received:
21
December 2010
Revised
received:
04
June 2011
Accepted:
14 June 2011
|
Abstract
Emblica officinalis,
commonly known as amla, is an important medicinal
plant of India.
Its fruits have potent antioxidant activity due to the presence of tannoids, tannins, vitamin C and flavonoids.?? The aim of this study was to investigate
the beneficial effect of the hydroalcoholic extract
of the fruits of Emblica officinalis
(EO) on memory impairment in Swiss albino mice. Scopolamine (1 mg kg-1,
i.p) was administered to induce amnesia and the
memory was evaluated by using elevated plus-maze and passive avoidance tests.
Piracetam (200 mg kg-1, i.p.) was used as a standard nootropic
agent. The EO extract was administered intraperitoneally
in four graded doses (150, 300, 450 and 600 mg kg-1) for 7
consecutive days to different groups of mice. The mice were sacrificed on the
8th day following assessment of memory.
The brain malondialdehyde (MDA) and glutathione
(GSH) as well as acetylcholinesterase (AchE)) activity was determined. It was observed that EO
extract reversed the amnesia induced by scopolamine. The mean transfer
latency and retention latency in the EO extract 600 mg kg-1 group vs the vehicle treated scopolamine group was 13.46 sec
(p<0.001) and 134.4 sec (p<0.001) vs 23.99
sec and 44.55 sec, respectively. EO extract treatment also significantly
(p<0.001) ameliorated the oxidative stress induced by scopolamine
administration. The mice brain MDA and GSH levels in the EO extract 600 mg kg-1
group vs the scopolamine group were 29.95 nmol g-1 of wet tissue and 51.87 mg
g-1 tissue vs 55.22 nmol
g-1 of wet tissue and 28.33 mg
g-1 tissue, respectively. Further, EO extract (300, 450 and 600 mg
kg-1, i.p) significantly (p<0.001)
reversed the rise in brain acetyl cholinesterase (AchE)
level induced by scopolamine. The mice brain AchE
levels in the EO extract 600 mg kg-1 group as compared to the
scopolamine group was 70.23 vs 151.49? U mg-1 protein-1,
respectively. These results suggest that EO possesses memory enhancing,
antioxidant and anti-cholinesterase activity. It may be useful for the
treatment of cognitive impairments induced by cholinergic dysfunction.? Its potential in the management of dementia
and Alzheimer disease needs to be further explored.??
Key
words
Alzheimer disease, Emblica officinalis,
Scopolamine, Amnesia ?
|
Copyright ? 2012 Triveni Enterprises. All rights reserved. No part
of the Journal can be reproduced in any form without prior
permission. Responsibility regarding the authenticity of the data, and
the acceptability of the conclusions enforced or derived, rest completely
with the author(s).
|